Eli Lilly contends it should be allowed to vet data from 340B hospitals before providing rebates, rather than offer upfront ...

Eli Lilly became the second drugmaker this week to sue the U.S. government for rejecting their proposed changes to a program ...

Lilly filed a lawsuit Nov. 14 against HHS head Xavier Becerra and the Health Resources and Services Administration for blocking a plan to change its 340B program from immediate discounts to offering ...

Reversing an earlier decision, European regulators recommended that the Alzheimer’s therapy Leqembi should be approved ...

Johnson & Johnson has filed a lawsuit seeking validation of its rebate model for 340B drugs, which offers post-sale rebates instead of upfront discounts. The initiative, criticized by hospitals and ...

The lawsuit is the second by a large drugmaker in recent days challenging how it provides required discounts to certain ...

Robert F. Kennedy Jr.’s selection Thursday as President-elect Donald Trump’s Health and Human Services secretary nominee sent shockwaves through Washington.

Robert F. Kennedy Jr, a prominent antivaccine activist and former independent presidential candidate, has been nominated to ...

AstraZeneca and Amgen announced that a Phase 3 trial of Tezspire (tezepelumab) showed a statistically significant and ...

Guggenheim's Inaugural Healthcare Innovation Conference November 12, 2024 2:00 PM ETCompany ParticipantsEmma Walmsley - Chief ...

The City of Decatur is helping people achieve a big goal through the Homebuyer Assistance Program. The basic requirements of ...

Medtech shouldn’t be greatly impacted if vaccine critic Robert F. Kennedy Jr. is appointed as head of HHS, according to a ...